Skip to content

The Outcomes of Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules

The Clinical Outcomes and Artificial Intelligence Prediction Model of Ultrasound-guided Thermal Ablation for the Treatment of Benign Thyroid Nodules:A Multicenter Prospective Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06340945
Enrollment
1500
Registered
2024-04-02
Start date
2024-04-01
Completion date
2029-12-31
Last updated
2026-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Nodules

Brief summary

1. To evaluate the clinical outcomes of ultrasound-guided thermal ablationfor the treatment of benign thyroid nodules; 2. To develop and validate a artificial intelligence model to predict the outcomes of ultrasound-guided thermal ablation in the treatment of benign thyroid nodules

Interventions

microwave ablation, radio frequency ablation, laser ablation

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \[1\]confirmation of benign nodule status on two separate fine- needle aspiration (FNA) or core-needle biopsy (CNB) \[2\]no suspicious malignant features on ultrasound examination \[3\]report of cosmetic and/ or symptomatic problems or concern of nodules growing rapidly or malignant transformation \[4\]refusal or ineligibility for surgery \[5\]follow-up time ≥6months

Exclusion criteria

1. follicular neoplasm or malignancy findings on biopsy 2. nodules with benign result on biopsy had suspicious of malignancy in US, including marked hypoechoic, ill-defined margins, taller-than-wide shape or microcalcifications 3. patients with cystic nodules 4. patients with contra-lateral vocal cord par- alysis 5. previous radiation to the head and neck 6. ; follow- up time less than 6 months

Design outcomes

Primary

MeasureTime frameDescription
volume reduction ratethrough study completion, an average of 6 monthsThe volume reduction rate (VRR)was calculated by the equations: VRR=(\[initial volume-final volume\] × 100)/initial volume
rate of nodule regrowththrough study completion, an average of 1 monthsRegrowth was defined as ≥50% volume increase compared to the previously recorded smallest volume during the follow-up

Secondary

MeasureTime frameDescription
rate of complications1 weekcomplications after ablation
cosmetic scorethrough study completion, an average of 6 monthsThe cosmetic score was assessed by a physician (1, no palpable mass; 2, no cosmetic problem but palpable mass; 3, a cosmetic problem on swallowing only; and 4, a readily detected cosmetic problem)
symptom scorethrough study completion, an average of 6 monthsThe symptom score was self-measured by patients using a 10-cm visual analogue scale (grade 0-10)
vital volumethrough study completion, an average of 6 monthsvital volume was the incompletely treated vital volume which located peripherally
total volumethrough study completion, an average of 6 monthsthe overall volume of the nodules

Countries

China

Contacts

CONTACTLin Yan, MD.
gemma-y@163.com8613811237313

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026